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Perinatal
Toxoplasmosis,
Northern Taiwan 
To the Editor: Toxoplasmosis is
caused by a protozoan parasite known
as Toxoplasma gondii, which is found
in animals worldwide and is readily
transmitted to humans. The preva-
lence of T. gondii–specific immuno-
globulin (IgG)  antibodies in women
ranges from ≈15% in the United
States (1) to ≈55% in Europe (2). Rate
of transmission to a fetus in the first,
second, and third trimesters is 8%,
25%, and 60%, respectively (3). The
rate of congenital toxoplasmosis in
the United States is 1–10 per 10,000
live births (4). Most infants infected
in utero are born without obvious
signs of toxoplasmosis, and learning
or visual disabilities do not develop in
up to 80% until their second or third
decade of life (5,6).
In 1985 in Taiwan, the prevalence
rates of T. gondii–specific IgG, as
determined by ELISA, for pregnant
women and their neonates were
10.2% and 11.6%, respectively. No
samples from mothers or neonates
were screened for IgM titers (7).
During the past 20 years, however, the
lifestyle, socioeconomic environment,
and healthcare system have changed
substantially in Taiwan. Overseas
traveling has become more conven-
ient, and Taiwan residents often travel
to toxoplasmosis-endemic areas. The
number of babies born to immigrant
mothers has also recently increased in
Taiwan. Our objective was to estimate
the seroprevalence of perinatally
transmitted  T. gondii in northern
Taiwan.
We tested sera collected from con-
secutive samples of women and their
neonates (live births only) at 1 med-
ical center, 1 local hospital, and 2
obstetric clinics in northern Taiwan
from April 2004 through January
2005, which was 1 investigation of
the Taiwan Birth Panel Study.
Informed consent was obtained from
either parent before enrollment in the
study. Serum samples from cord
blood of 483 neonates and paired
samples from their mothers were ana-
lyzed for T. gondii–specific IgG and
IgM titers by ELISA (Diagnostic
Products Corporation, Los Angeles,
CA, USA) (IgG sensitivity 94%,
specificity 100%; IgM sensitivity
96.9%, specificity 91%) (8). Samples
from the mothers were tested within 2
days of delivery. Additional data
about health measures and conditions
were collected by trained interviewers
using structured questionnaires. 
Among the study population, 93%
were Taiwanese, 0.6% were
Taiwanese aboriginals, 2.5% were
mainland Chinese, and 3.9% were
immigrants from southeastern Asia.
Of the 483 mothers, 0.6% worked as
farmers, 76% were 25–35 years of
age, >50% had a university-level edu-
cation, 77.7% encountered pets daily,
and 9.7% owned cats. Of the 483
infants, the male:female ratio was
50.8:49.2, delivery was premature for
8.6%, and 5.8% had a low birth-
weight. For the mothers, the T.
gondii–specific IgG prevalence rate
was 9.1% (95% confidence interval
[CI] 6.5%–11.7%), and 5 mothers
(1.0%; 95% CI 0.1%–1.9%) were
IgM positive. The T. gondii–specific
IgG prevalence rate for the neonates
was 9.3% (95% CI 6.7%–11.9%), and
1 neonate (0.2%; 95% CI 0%– 0.6%)
was IgM positive (Table). 
We identified 2 risk factors for
seropositive mothers: being fromLETTERS
mainland People’s Republic of China
(odds ratio [OR] 13.42; 95% CI
1.29–19.49] and being an agricultural
worker (OR 59.53; 95% CI 4.45–
79.67). Incidence of positive IgG
titers was higher for mothers who
owned cats than for mothers who did
not own cats, but not significantly
higher. The neonates who had positive
T. gondii–specific IgM had negative
IgM results at the age of 3 months. No
significant differences in gestational
age, birthweight, and neurodevelop-
ment were identified between
seropositive and seronegative groups
of infants.
This study showed that in northern
Taiwan, seroprevalence of T. gondii
among pregnant women and neonates
remains low and has not substantially
changed during the past 20 years. The
reason for such a low incidence in
Taiwan is not clear but may be attrib-
uted to differences in the lifestyle, cli-
mate, cultural differences, food
habits, and to the lesser consumption
of raw meat in Taiwan compared with
western countries. We found that the
rate for T. gondii–specific IgM is
higher for mainland Chinese mothers
than for Taiwanese mothers (p<0.05).
In Taiwan, the percentage of immi-
grant mothers increased from 15.7%
in 1998 to 32.1% in 2003, and the per-
centage of neonates born to these
mothers increased from 5.1% in 1998
to 13.8% in 2004 (9). Whether the
lifestyle of mothers in Taiwan with a
different ethnicity will influence
future  T. gondii seroprevalence
require further investigation. This
study highlights the emerging impor-
tance of toxoplasmosis as a possible
perinatal infection in Taiwan. A high
index of suspicion for infectious dis-
eases among immigrant mothers is
needed (10).
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